These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3025 related articles for article (PubMed ID: 28008784)

  • 21. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
    Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
    Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective.
    Vemuri R; Gundamaraju R; Shastri MD; Shukla SD; Kalpurath K; Ball M; Tristram S; Shankar EM; Ahuja K; Eri R
    Biomed Res Int; 2018; 2018():4178607. PubMed ID: 29682542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor Considerations in Fecal Microbiota Transplantation.
    Barnes D; Park KT
    Curr Gastroenterol Rep; 2017 Mar; 19(3):10. PubMed ID: 28289858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
    Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
    J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intestinal microbiota in individualized therapies].
    Witte T; Pieper DH; Heidrich B
    Internist (Berl); 2017 Jul; 58(7):682-686. PubMed ID: 28540475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness.
    Wischmeyer PE; McDonald D; Knight R
    Curr Opin Crit Care; 2016 Aug; 22(4):347-53. PubMed ID: 27327243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic and Modulation of Microbiota: A New Paradigm?
    Rizzatti G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic administration and the development of obesity in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2016 Mar; 47(3):171-7. PubMed ID: 26895606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
    Vindigni SM; Broussard EK; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.
    Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM
    JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 152.